Transforming Cancer Treatment
OncoNOx
  • Lead compounds are powerful anticancer drugs
  • Proof-of-concept demonstrated in mouse models of human cancer
  • Synergy in vitro with commonly used chemotherapeutic agents
  • Strong scientific team with ties to top universities
  • Highly experienced management team

OncoNOx ApS

OncoNOx develops novel, proprietary anti-cancer agents. Using our unique medicinal chemistry approach, we transform already marketed compounds into powerful cytotoxic drugs, which potently inhibit cancer in validated animal models

Read more here - About OncoNOx